Taranabant

Taranabant (codenamed MK-0364) is a cannabinoid receptor type 1 inverse agonist being investigated as a potential treatment for obesity due to its anorectic effects.^[1]^[2] It was discovered by Merck & Co.

In October 2008, Merck has stopped its phase III clinical trials with the drugs due to high level of central side effects, mainly depression and anxiety.^[3]^[4]^[5]^[6]

References

Antiobesity agents/Anorectics (A08)

Central

Stimulants	4-Methylamphetamine Amfecloral Amfepentorex Amfepramone Aminorex Amphetamine Amphetaminil Atomoxetine Benfluorex^‡ Benzphetamine Bupropion (+naltrexone^†; +zonisamide^†) Cathine Cathinone Chlorphentermine Ciclazindol Clobenzorex Cloforex Clominorex Clortermine Dexfenfluramine Dextroamphetamine Dextromethamphetamine Dexmethylphenidate Difemetorex Dimethylcathinone Diphemethoxidine Ephedrine Ephedra Etilamfetamine Etolorex Fenbutrazate Fencamfamine Fenethylline Fenfluramine (+phentermine^‡) Fenproporex Fludorex Fluminorex Furfenorex Indanorex Khat Levopropylhexedrine Lisdexamfetamine Manifaxine Mazindol Mefenorex Methamphetamine Methylphenidate Norfenfluramine Pemoline Pentorex Phendimetrazine Phenethylamine Phenmetrazine Phentermine (+topiramate) Phenylpropanolamine Pipradrol Prolintane Propylhexedrine Pseudoephedrine Pyrovalerone Radafaxine Reboxetine Setazindol Sibutramine Synephrine Tesofensine Viloxazine Xylopropamine Zylofuramine

Cannabinoids	Drinabant^§ • Ibipinabant^§ • Otenabant^§ • Rimonabant^‡ • Rosonabant^§ • Surinabant^§ • Taranabant^§

Others	5-HTP • Galactomannan (Guar gum) • Glucomannan • L-DOPA • L-Phenylalanine • L-Tryptophan • L-Tyrosine • Lorcaserin • Lu AA-33810 • Metformin • Naltrexone • Naloxone • Oxyntomodulin • P57 • Peptide YY • Topiramate • Yohimbine (Yohimbe) • Zonisamide

Peripheral

Cetilistat • 2,4-Dinitrophenol^‡ • Dirlotapide • Mitratapide • Oleoyl-estrone • Orlistat • Simmondsin • Sterculia

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

M: NUT

cof, enz, met

noco, nuvi, sysi/epon, met

drug (A8/11/12)

Cannabinoids

Phytocannabinoids

Cannabinoid
metabolites

8,11-DiOH-THC
11-COOH-THC
11-OH-THC

Endogenous
cannabinoids

Arachidonoyl ethanolamide (Anandamide or AEA)
2-Arachidonoylglycerol (2-AG)
2-Arachidonyl glyceryl ether (noladin ether)
N-Arachidonoyl dopamine (NADA)
Oleamide
RVD-Hpα
Virodhamine

Synthetic
cannabinoid
receptor
agonists

Classical cannabinoids (Dibenzopyrans)	A-40174 A-41988 A-42574 Ajulemic acid AM-087 AM-411 AM-855 AM-905 AM-906 AM-919 AM-926 AM-938 AM-2389 AM-4030 AMG-1 AMG-3 AMG-36 AMG-41 Dexanabinol (HU-211) DMHP Dronabinol HHC HU-210 HU-243 JWH-051 JWH-133 JWH-139 JWH-161 JWH-229 JWH-359 KM-233 L-759,633 L-759,656 Levonantradol (CP 50,5561) Menabitan Nabazenil Nabidrox (Canbisol) Nabilone Nabitan Naboctate O-224 O-581 O-774 O-806 O-823 O-1057 O-1125 O-1191 O-1238 O-2048 O-2113 O-2365 O-2372 O-2373 O-2383 O-2426 O-2484 O-2545 O-2694 O-2715 O-2716 O-3223 O-3226 Parahexyl Pirnabine THC-O-acetate THC-O-phosphate

Nonclassical cannabinoids	Cannabicyclohexanol CP 47,497 (C6)-CP 47,497 (C9)-CP 47,497 CP 55,244 CP 55,940 HU-308 HU-320 HU-331 HU-336 HU-345 HU-910 Nonabine O-1376 O-1422 O-1601 O-1656 O-1657 O-1660 O-1871 SPA-229 Tinabinol 2-Isopropyl-5-methyl-1- (2,6-dihydroxy-4-nonylphenyl)cyclohex-1-ene

Benzoylindoles	1-Butyl-3-(2-methoxybenzoyl)indole 1-Butyl-3-(4-methoxybenzoyl)indole 1-Pentyl-3-(2-methoxybenzoyl)indole AM-630 AM-679 AM-694 AM-1241 AM-2233 GW-405,833 (L-768,242) Pravadoline RCS-4 WIN 54,461

Naphthoylindoles	AM-1220 AM-1221 AM-1235 AM-2201 AM-2232 EAM-2201 JWH-007 JWH-015 JWH-018 JWH-019 JWH-073 JWH-081 JWH-098 JWH-116 JWH-122 JWH-149 JWH-164 JWH-182 JWH-193 JWH-198 JWH-200 JWH-210 JWH-398 JWH-424 MAM-2201 WIN 55,212-2

Naphthylmethylindoles	JWH-175 JWH-184 JWH-185 JWH-192 JWH-194 JWH-195 JWH-196 JWH-197 JWH-199

Phenylacetylindoles	Cannabipiperidiethanone JWH-167 JWH-203 JWH-249 JWH-250 JWH-251 JWH-302 RCS-8

Naphthoylpyrroles	JWH-030 JWH-147 JWH-307 JWH-369 JWH-370

Eicosanoids	AM-883 AM-1346 ACEA ACPA Methanandamide (AM-356) O-585 O-689 O-1812 O-1860 O-1861

Others	4-HTMPIPO 5-Fluoropentyl-3-pyridinoylindole 5F-PB-22 A-796,260 A-834,735 A-836,339 A-955,840 Abnormal cannabidiol AB-001 AB-FUBINACA AB-PINACA ADB-FUBINACA ADBICA AM-1248 AM-1714 APINACA AZ-11713908 BAY 38-7271 BAY 59-3074 CB-13 CB-86 CBS-0550 GW-842,166X JWH-176 JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-7 MDA-19 NESS-040C5 NMP-7 O-889 O-1269 O-1270 O-1399 O-1602 O-2220 Org 28312 Org 28611 PF-03550096 PSB-SB-1202 QUCHIC QUPIC S-444,823 SDB-001 (2NE1) SDB-006 SER-601 STS-135 Tedalinab UR-12 (MN-25) UR-144 URB-447 VSN-16 WIN 56,098 XLR-11

Allosteric
modulators of
cannabinoid
receptors

Org 27569
Org 27759
Org 29647
RTI-371

Endocannabinoid
activity enhancers

4-Nonylphenylboronic acid
AM-404
Arachidonoyl serotonin
Arvanil
Biochanin A
CAY-10401
CAY-10429
Genistein
IDFP
JNJ 1661010
JZL184
JZL195
Kaempferol
LY-2183240
O-1624
O-2093
Oleoylethanolamide (OEA)
Olvanil
Palmitoylethanolamide (PEA)
PF-04457845
PF-622
PF-750
PF-3845
PHOP
URB-447
URB-597
URB-602
URB-754
VDM-11

Cannabinoid
receptor
antagonists and
inverse agonists

AM-251
AM-281
AM-630
AM-1387
AM-4113
AM-6527
AM-6545
BML-190
CAY-10508
CB-25
CB-52
CB-86
Drinabant (AVE1625)
Hemopressin
Ibipinabant (SLV319)
JTE-907
LH-21
LY-320,135
MDA-77
MJ-15
MK-9470
NESS-0327
NIDA-41020
O-606
O-1184
O-1248
O-1918
O-2050
O-2654
Otenabant (CP-945,598)
PF-514273
PipISB
PSB-SB-487
Rimonabant (SR141716)
Rosonabant (E-6776)
SR-144,528
Surinabant (SR147778)
Taranabant (MK-0364)
TM-38837
VCHSR

This cannabinoid related article is a stub. You can help World Heritage Encyclopedia by expanding it.

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.

Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.

By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Taranabant

Taranabant

See also

References

Suggestions

Cannabinoid receptor antagonist

Encyclopedia Article